Диссертация (1146649), страница 25
Текст из файла (страница 25)
– P. 56–58.233. Peptide binding characteristics of the coeliac disease-associatedDQ(alpha1*0501, beta1*0201) molecule / Y. Van de Wal [et al.] // Immunogenetics. – 1996. – Vol. 44, Issue 4. – P. 246–253.234. Phase 3 study of ataluren (PTC124) in nonsense mutation cystic fibrosis (nmCF): baseline data / E. Kerem [et al.] // Journal of Cystic Fibrosis. – 2011. –Vol.
10, Suppl. 1. – P. S17.235. Prevalence of celiac disease among blood donors in Brazil /L. Gandolfi [et al.] // The American journal of gastroenterology. – 2000. – Vol. 95,Issue 3. – P. 689–692.236. Prevalence of celiac disease in at-risk and not-at-risk groups in theUnited States: a large multicenter study / A. Fasano [et al.] // Archives of internalmedicine. 2003. Vol.
163, No. 3. P. 286–292.145237. Prevalence of celiac disease in Egyptian children disputes the eastwest agriculture-dependent spread of the disease / M. Abu-Zekry [et al.] // Journalof Pediatric Gastroenterology and Nutrition. – 2008. – Vol. 47, Issue 2. – P. 136–140.238. Prevalence of celiac disease in Tunisian blood donors / F. Bdioui [etal.] // Gastroentérologie Clinique et Biologique.
– 2006. – Vol. 30, Issue 1. –P. 33–36.239. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) / C.E. Bear [et al.] // Cell. – 1992. –Vol. 68, Issue 4. – P. 809–818.240. Quinton, P.M. Cystic fibrosis: a disease in electrolyte transport /P.M. Quinton // FASEB journal. – 1990. – Vol. 4. – P. 2709–2717.241.
Rawashdeh, M.O. Celiac disease in Arabs / M.O. Rawashdeh,B. Khalil, E. Raweily // Journal of Pediatric Gastroenterology and Nutrition. –1996. – Vol. 23, Issue 4. – P. 415–418.242. Regulation of male fertility by CFTR and implications in male infertility / H.
Chen [et al.] // Human reproduction update. – 2012. – Vol. 18, Issue 6. –P. 703–713.243. Rescue of the protein folding defect in cystic fibrosis in vitro by theinvestigational small molecule, VX-809 / F. Van Goor [et al.] // Journal of cysticfibrosis.
– 2010. – Vol. 9, Suppl. 1. – P. S14.244. Revised criteria for diagnosis of coeliac disease / J.A. Walker-Smith[et al.] // Archives of Disease in Chidhood. – 1990. – Vol. 65, Issue 8. – P. 909–911.245. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients / E. Deneuville [et al.] // American journalof respiratory and critical care medicine. – 1997. – Vol.
156, Issue 1. – P. 166–172.246. Role for PKC alpha and PKC epsilon in down-regulation of CFTR180 mRNA in a human epithelial liver cell line / S. Kang-Park [et al.] // Journal ofhepatology. — 1998. – Vol. 28, Issue 2. – P. 250–262.146247. Schechter, M.S. Non-genetic influences on CF lung disease: the roleof sociodemographic characteristics, environmental exposures and healthcare interventions / M.S. Schechter // Pediatric pulmonology.
– 2004. – Vol. 37,Suppl. 26. – P. 82–85.248. Schöni, M.H. Nutrition and lung function in cystic fibrosis patients:review / M.H. Schöni, C. Casaulta-Aebischer // Clinical nutrition. – 2000. –Vol. 19, Issue 2. – P. 79–85.249. Screening of the adult population in Iran for coeliac disease: comparison for the tissue-transglutaminase antibody and anti-endomysial antibody tests /M.R. Akbari [et al.] // European Journal of Gastroenterology and Hepatology.
–2006. – Vol. 18, Issue 11. – P. 1181–1186.250. Screening of tissue transglutaminase antibody in healthy blood donorsfor celiac disease screening in the Turkish population / G. Tatar [et al.] // DigestiveDiseases and Science. – 2004. – Vol. 49, Issue 9. – P. 1479–1484.251. Selective deamidation by tissue transglutaminase strongly enhancesgliadin-specific T cell reactivity / Y. Van de Wal [et al.] // Journal of immunology.
– 1998. – Vol. 161, Issue 4. – P. 1585–1588.252. Seroprevalence, correlates, and characteristics of undetected coeliacdisease in England / West J. [et al.] // Gut. 2003. Vol. 52 (7). P. 960–965.253. Sokol, R.J. Recommendations for Management of Liver and BiliaryTract Disease in Cystic Fibrosis / R.J. Sokol, P.R. Durie // Journal of pediatric gastroenterology and nutrition. – 1999. – Vol.
28. – P. S1–S13.254. Sollid, L.M. Evidence for primary association of celiac disease to aparticular HLA-DQ a/b heterodimer / L.M. Sollid // The Journal of ExperimentalMedicine. 1989. Vol. 169. P. 345.255. Sollid, L.M. HLA susceptibility genes in celiac disease genetic mapping and role in pathogenesis / L.M. Sollid, E.
Thorsby // Gastroenterology. –1993. – Vol. 105 (3). – P. 910–922.256. Sollid, L.M. Molecular basis of celiac disease / L.M. Sollid // Annualreview of immunology. – 2000. – Vol. 18. – P. 53–81.147257. Sollid, L.M. Celiac disease genetics: current concepts and practicalapplications / L.M. Sollid, B.A. Lie // Clinical Gastroenterology and Hepatology. –2005.
– Vol. 3, Issue 9. – P. 843–851.258. Standards of care for patients with cystic fibrosis: a European consensus / Kerem E. [et al.] // Journal of cystic fibrosis. – 2005. – Vol. 4, Issue 1. – P. 7–26.259. Structural Basis for Gluten Intolerance in Celiac Sprue / L. Shan [etal.] // Science. – 2002. – Vol. 297, Issue 5590.
– 2275–2279.260. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease / C.Y. Kim [et al.] // Proceedings of the National Academyof Sciences of the United States of America. – 2004. – Vol. 101, Issue 12. –P. 4175–4179.261. Stuart, B.M. Atrophy of the coeliac mucosa / B.M.
Stuart, A.E. Gent //European journal of gastroenterology and hepatology. – 1998. – Vol. 10, Issue 6. –P. 523–525.262. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease / M. Bodd [et al.] // Gastroenterology. – 2012. – Vol. 142 (3). – P. 552–561.263. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8celiac disease patient preferentially recognize gliadin when presented by DQ8 /K.E.A. Lundin [et al.] // Human Immunology. – 1994. – Vol.
41, Issue 4. – P. 285–291.264. The estimated incidence of cystic fibrosis in Japan / Y. Yamashiro [etal.] // Journal of Pediatric Gastroenterology and Nutrition. – 1997. – Vol. 24, Issue 5. – P. 544–547.265. The first large population based twin study of coeliac disease /L. Greco [et al.] // Gut. – 2002. – Vol. 50 (5). – P. 624–628.266. The iceberg of celiac disease: what is below the waterline? / J. West[et al.] // Clinical Gastroenterology and Hepatology. – 2007.
– Vol. 5, Issue 1. –P. 59–62.148267. The MYO9B gene is a strong risk factor for developing refractory celiac disease / V.M. Wolters [et al.] // Clinical Gastroenterology and Hepatology. – 2007. – Vol. 5, Issue 12. – P. 1399–1405.268. The prevalence of celiac disease in average-risk and at-risk WesternEuropean populations: a systematic review / C. Dube [et al.] // Gastroenterology. 2005. Vol. 128 (4 suppl. 1). Р. S57–S67.269. The prevalence of unrecognized adult celiac disease in Central Anatolia / S.
Gursoy [et al.] // Journal of Clinical Gastroenterology. – 2005. – Vol. 39,Issue 6. – P. 508–511.270. The use of a single serological marker underestimates the prevalenceof celiac disease in Israel: a study of blood donors / R. Shamir [et al.] // The American journal of gastroenterology.
– 2002. – Vol. 97, Issue 10. – P. 2589–2594.271. Tietge, U. Neurological complications in coeliac disease / U. Tietge,H. Schmidt, M. Manns // The American journal of gastroenterology. – 1997. –Vol. 92, Issue 3. – P. 540.272. Tissue transglutaminase selectively modifies gliadin peptides that arerecognized by gut-derived T cells in celiac disease / O. Molberg [et al.] // NatureMedicine. – 1998.
– Vol. 4, Issue 6. – P.713–717.273. Toll-like receptor 4 (TLR4) gene polymorphisms in celiac disease /I. Santin [et al.] // Tissue antigens. – 2007. – Vol. 70, Issue 6. – P. 495–498.274. Tsui, L.-C. The spectrum of cystic fibrosis mutations / L.-C. Tsui //Trends in Genetics. 1992. Vol. 8, No. 11. P. 392–398.275. VX-770 in subjects with cystic fibrosis who are homozygous for theF508del-CFTR mutation / P.A. Flume [et al.] // Journal of Cystic Fibrosis.
–2011. – Vol. 10, Suppl. 1. – P. S16.276. Walters, S. Epidemiology of cystic fibrosis / S. Walters, A. Mehta //Cystic fibrosis: book / edited by M. Hodson, D. Geddes, A. Bush. – 3rd ed. – London : Hodder Arnold, 2007. – P. 21–45.277. Wasting as an independent predictor of mortality in patients with cystic fibrosis / R. Sharma [et al.] // Thorax.
– 2001. – Vol. 56 (10). – P. 746 – 750.149278. Welsh, M.J. Molecular Mechanisms of CFTR Chloride Channel Dysfunction in Cystic Fibrosis / M.J. Welsh, A.E. Smith // Cell. – 1993. – Vol. 73, Issue 7. – P. 1251–1254.279. Why is coeliac disease endemic in the people of the Sahara? /C. Catassi [et al.] // The Lancet. 1999. Vol.
354, No. 9179. P. 647.280. Wilschanski, M. Patterns of GI disease in adulthood associated withmutations in the CFTR gene / M. Wilschanski, P.R. Durie // Gut. – 2007. – Vol. 56(8). – P. 1153–1163.281. Wolters, V.M. Genetic background of celiac disease and its clinicalimplications / V.M. Wolters, C. Wijmenqa // The American journal of gastroenterology.
– 2008. – Vol. 103, Issue 1. – P. 190–195.282. Zhernakova, A. The autoimmune puzzle – shared and specific genetics of immune-related disease / A. Zhernakova. – Utrecht : Gildeprint Drukkerijen,2009. – 304 p.283. Zielenski, J. Genotype and phenotype in cystic fibrosis / J. Zielenski //Respiration. – 2000. – Vol. 67, No. 2. – P.
117–133.284. Zielenski, J. Cystic fibrosis: genotypic and phenotypic variations /J. Zielenski, L.-C. Tsui // Annual review of genetics. – 1995. – Vol. 29. – P. 777–807.150ПРИЛОЖЕНИЯ151Приложение 1Опросник жалоб больных наследственными заболеваниями с синдромоммальабсорбции1. Жалобы со стороны пищеварительной системы: Боли в животелокализация:иррадиация:характер:интенсивность:продолжительность:условия вознокновения:связь с приемом пищи:условия купирования: Нарушение стулачастота стула в сутки и в неделю:консистенция и форма стула:наличие видимых патологичсеких примесей – слизи, крови, гноя: Диспепсические расстройстваотрыжка воздухом, горьким, съеденной пищей:изжога:урчание и вздутие живота:тошнота:тяжесть в эпигастрии после приема пищи: Изменение аппетитаснижение аппетита:повышение аппетита: Снижение массы тела (за какой период и на сколько кг, в процентахот массы тела):2.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
